Cancer Research UK
Therapeutic Catalyst
Expression of interest deadline; scheme was paused and expected to relaunch early July 2026. Next EOI deadline after relaunch: 25 September 2026.
Last verified:
Details
| Funder | Cancer Research UK |
| Budget | Up to £250k |
| Deadline | 25 September 2026 |
| Duration | Up to 18 months |
| Consortium | No |
| Application | 2-stage: expression of interest → full proposal |
| Frequency | Annual |
| Eligible countries | GB |
Eligibility & scope
Supports exploratory drug discovery to validate and de-risk targets for novel single-agent anti-cancer therapeutics. Open to academic researchers worldwide with their own lab or independent research. Projects run collaboratively with Cancer Research Horizons' Therapeutic Innovation team. Not suitable for basic biological research, combination studies, or drug repurposing.
More from Cancer Research UK
Prevention and Population Programme Award
Deadline: 15 Jul 2026Up to £2.5mEarly Detection and Diagnosis Programme Award
Deadline: 21 Jul 2026Up to £2.5mSenior Cancer Research Fellowship
Deadline: 10 Sept 2026Typically up to £1.75mClinician Scientist Fellowship
Deadline: 10 Sept 2026Typically up to £1mCareer Development Fellowship
Deadline: 10 Sept 2026Typically up to £1.5m
Browse Related
Could Therapeutic Catalyst be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →